4basebio receives MHRA licence for synthetic DNA manufacture
GMP certification enables 4basebio to supply DNA for clinical trials 4basebio PLC has been granted Good Manufacturing Practice (GMP) certification...
Selected News
NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma
Advancing care for stage 3 or 4 Hodgkin lymphoma patients The National Institute for Health and Care Excellence (NICE) has...
Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK
Collaboration expands AI-based risk profiling tools Diagnexia has announced a partnership with Stratipath AB to bring Stratipath Breast, an AI-based...
Genome editing offers hope for genetic hearing loss
New therapy developed to repair GJB2 R75W mutation Scientists from Juntendo University and The University of Tokyo have created an...
Amivantamab plus lazertinib shows survival benefit in lung cancer
Janssen drug combination extends life expectancy during trial Janssen-Cilag International NV has announced results from the phase 3 MARIPOSA study,...
Nouscom reveals promising results for lynch syndrome immunotherapy
NOUS-209 shows potential to intercept cancer in its early stages Nouscom has announced full safety and immunogenicity results from its...
WHO adds first maternal RSV vaccine to prequalification list
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants The World Health Organization (WHO) has announced that it has...
UK expands mandatory infectious disease reporting requirements
The update is aimed at strengthening local and national surveillance The UK Health Security Agency (UKHSA) has announced that it...
Orca Bio’s T-cell therapy shows promise in haematological malignancies
The company is preparing to submit the results to the FDA this year Orca Bio has shared promising results from...
UKHSA announces new effort to tackle hepatitis C
The agency has launched a whole genome sequencing service to monitor the virus The UK Health Security Agency (UKHSA) has...
Anocca announces authorisation pancreatic cancer trial
VIDAR-1 trial marks company's clinical-stage debut Anocca has achieved regulatory approval for its first clinical trial, VIDAR-1, a major milestone...
Careology and Entia join forces to transform cancer care
Collaboration brings remote care to cancer patients Careology and Entia have announced a partnership to enhance cancer care through innovative...
Rxulti approved in the European Union for adolescent schizophrenia
EC extends brexpiprazole indication to include adolescents Otsuka Pharmaceutical Europe and Lundbeck have announced that the European Commission has approved...
Grifols clinical trial shows positive results for post-polio patients
Immunoglobulin therapy improves mobility in phase 2/3 study Grifols has announced positive results from its phase 2/3 clinical trial evaluating...
Minoryx doses first patient with leriglitazone in Rett syndrome study
Phase 2a TREE study assesses safety and efficacy of leriglitazone Minoryx Therapeutics has dosed the first patient in its phase...
Orphelia Pharma explores other pathways for paediatric cancer treatment
Company seeks new direction after negative CHMP opinion on KIZFIZO Orphelia Pharma is exploring alternative regulatory pathways for KIZFIZO after...
Agomab announces positive phase 2a interim results for AGMB-129
FSCD therapy meets all endpoints in interim analysis Agomab Therapeutics NV (Agomab) has announced positive interim results from 44 patients...
Pfizer’s Talzenna therapy accepted for use within NHS Scotland
Scottish Medicines Consortium approves new option for mCRPC patients Pfizer Ltd has announced that the Scottish Medicines Consortium (SMC) has...
SECuRE trial pre-chemo participants experience PSA level drops
Cohort expansion phase commences with promising results The Safety Review Committee (SRC) has confirmed the end of the Dose Escalation...
Rotherham NHS Foundation Trust enhances patient engagement
Innovative digital transformation leads to significant improvements To reduce waiting lists and enhance patient communication, Rotherham NHS Foundation Trust has...
